This content is from: Patents

US and China IP experts call for reforms to boost Chinese pharmaceutical industry

The US-China IP Cooperation Dialogue Report says that greater protection for innovators is needed to unleash the potential of China's pharmaceutical industry

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial